Johan Nilsson

Johan Nilsson (MD, PhD) is a resident physician specializing in clinical pharmacology and has been working with CTC since 2020. He has experience as principal investigator and co-investigator in more than 50 clinical trials in all phases, including First-in-Human (FIH).

Johan has a special interest in psychiatry, in particular treatment of affective disorders, and education. He has a PhD in psychiatric epidemiology and he is a serving board member and chairman of KognioTM, a prominent Swedish centre for education and training in Cognitive Behavioral Therapy (CBT).